| scholarly article | Q13442814 |
| P2093 | author name string | Nakamura H | |
| Tokuda Y | |||
| Yoshimura M | |||
| Shimamura K | |||
| Ohnishi Y | |||
| Tamaoki N | |||
| Ueyama Y | |||
| Iwasawa M | |||
| P2860 | cites work | Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists | Q67883623 |
| Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells | Q67970501 | ||
| Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue | Q68131177 | ||
| Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer | Q68290745 | ||
| Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies | Q72228246 | ||
| Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product | Q28256232 | ||
| Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies | Q28282033 | ||
| Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene | Q28286890 | ||
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
| Growth factor receptor tyrosine kinases | Q34164164 | ||
| Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells | Q36684680 | ||
| p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor | Q36767887 | ||
| Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth | Q37600965 | ||
| Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene | Q40659427 | ||
| A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines | Q41668009 | ||
| Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification. | Q41690323 | ||
| p185neu expression in human lung adenocarcinomas predicts shortened survival | Q41725055 | ||
| Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies | Q42819445 | ||
| Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo | Q44708292 | ||
| Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. | Q45166137 | ||
| Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues | Q46076087 | ||
| Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
| Amplification of a novel v-erbB-related gene in a human mammary carcinoma | Q48375434 | ||
| Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents. | Q54943265 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 969-973 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody | |
| P478 | volume | 71 |
| Q40840650 | A Humanized Anti-c-erbB-2 Monoclonal Antibody for the Treatment of Breast Cancer |
| Q40184647 | Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo |
| Q40227146 | Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu |
| Q42834569 | Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor |
| Q34244922 | Clinical development of trastuzumab in breast cancer |
| Q38729111 | ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology |
| Q36438366 | Establishing a link between oncogenes and tumor angiogenesis |
| Q40930413 | H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo |
| Q41438696 | HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. |
| Q34211018 | Herceptin: from the bench to the clinic |
| Q39664471 | High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K |
| Q39993985 | In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product |
| Q40759616 | Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme. |
| Q40857892 | The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice |
| Q34103663 | Tyrosine kinases and gastric cancer |
| Q35110970 | p185, an immunodominant epitope, is an autoantigen mimotope. |
Search more.